CONTRAVE

This brand name is authorized in United States. It is also authorized in Canada, Ecuador, Hong Kong SAR China, New Zealand.

Active ingredients

The drug CONTRAVE contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII Z6375YW9SF - NALTREXONE HYDROCHLORIDE
 

Naltrexone is an orally used, long acting specific opioid antagonist. Naltrexone binds competitively to receptors which are located in the central and peripheral nervous system and hence blocks the access for exogenously administered opioids.

 
Read more about Naltrexone
2
UNII ZG7E5POY8O - BUPROPION HYDROCHLORIDE
 

Bupropion is a selective inhibitor of the neuronal re-uptake of catecholamines (noradrenaline and dopamine) with minimal effect on the re-uptake of indolamines (serotonin) and does not inhibit either monoamine oxidase. The mechanism by which bupropion enhances the ability of patients to abstain from smoking is unknown. However, it is presumed that this action is mediated by noradrenergic and/or dopaminergic mechanisms.

 
Read more about Bupropion

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 CONTRAVE Extended-release tablet MPI, US: SPL/PLR FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A08AA62 A Alimentary tract and metabolism → A08 Antiobesity preparations, excl. diet products → A08A Antiobesity preparations, excl. diet products → A08AA Centrally acting antiobesity products
Discover more medicines within A08AA62

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
CA Health Products and Food Branch 02472945
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 5906-MEE-0121
HK Department of Health Drug Office 66934
NZ Medicines and Medical Devices Safety Authority 20867
US FDA, National Drug Code 43063-772, 50090-2945, 51267-890

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.